Can ulcerative colitis involve the small intestine, such as the terminal ileum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Ulcerative Colitis Affect the Small Bowel?

Ulcerative colitis is by definition limited to the colon, but approximately 20% of patients with extensive colitis develop "backwash ileitis"—a continuous extension of inflammation from the cecum into the terminal ileum that represents the only form of small bowel involvement in UC. 1, 2

Definition and Mechanism

  • UC is characterized by diffuse mucosal inflammation limited to the colon, distinguishing it fundamentally from Crohn's disease which can affect any part of the gastrointestinal tract. 1

  • The inflammation in UC is restricted to the mucosa and occasionally submucosa, never transmural like Crohn's disease. 3, 4

  • Backwash ileitis occurs when colonic inflammation extends continuously from the cecum into the terminal ileum without skip lesions, affecting up to 20% of patients with pancolitis or extensive colitis. 5, 2, 6

Key Distinguishing Features from Crohn's Disease

When evaluating potential small bowel involvement in a patient with colitis, the critical differentiating features are:

  • UC with backwash ileitis shows continuous inflammation extending from the cecum, whereas Crohn's disease demonstrates skip lesions and patchy distribution throughout the small bowel. 2

  • The inflammation in backwash ileitis is mild, typically involving only a few centimeters of terminal ileum without discrete ulceration, while Crohn's ileitis shows deeper ulcers, strictures, and transmural involvement. 5

  • Pyloric gland metaplasia has not been identified in ileal biopsies from UC patients with backwash ileitis, but is common in Crohn's disease affecting the ileum. 7

  • Rectal involvement is nearly universal in UC (>97% of cases), while rectal sparing is common in Crohn's disease, making this a key distinguishing feature. 2

Clinical Implications and Prognosis

  • Patients with backwash ileitis are prone to more refractory disease course, including an increased risk of colon neoplasia in proctocolectomy specimens. 2, 8

  • When macroscopic backwash ileitis is identified, additional small bowel imaging (CT/MR enterography) should be obtained to differentiate UC from Crohn's disease and assess the full extent of disease. 2, 8

  • Small bowel radiology or capsule endoscopy is NOT routinely recommended in UC unless there are atypical features suggesting possible Crohn's disease. 2

Diagnostic Pitfalls to Avoid

  • Do not diagnose Crohn's disease based solely on terminal ileal inflammation in a patient with pancolitis—backwash ileitis is a recognized variant of UC. 5, 2

  • Evaluate for rectal sparing, skip lesions, or discrete ileal ulcers, as these features favor Crohn's disease over UC with backwash ileitis. 5, 2

  • In 5-15% of IBD patients, classification remains uncertain (IBD-unclassified) when endoscopic and histological assessments cannot distinguish between Crohn's colitis and UC; capsule endoscopy can establish a definitive diagnosis by demonstrating small bowel lesions in 17-70% of these cases. 2

  • Patchiness of inflammation can occur in UC, particularly in pediatric patients or after treatment initiation, so this finding alone should not automatically lead to a Crohn's disease diagnosis. 5

References

Guideline

Ulcerative Colitis and Small Bowel Involvement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Terminal Ileitis and Diarrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Ileitis in Patients with Colon Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.